24 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1310118	32	Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding.	Merck Sharp and Dohme Research Laboratories
25254640	64	Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.	Syntrix Biosystems
19171482	22	Discovery of small molecule human C5a receptor antagonists.	Astrazeneca
18378452	64	Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists.	Johnson & Johnson Prd
11931608	17	Inhibition of protein-protein association by small molecules: approaches and progress.	Pfizer
	36	A nonpeptidic agonist ligand of the human C5a receptor: Synthesis, binding affinity optimization and functional characterization	TBA
20527893	120	Selective hexapeptide agonists and antagonists for human complement C3a receptor.	The University of Queensland
20004096	49	Identification of a new class of small molecule C5a receptor antagonists.	Wyeth Research
	21	New non peptidic C5a receptor antagonists	TBA
18809326	36	Small, non-peptide C5a receptor antagonists: part 1.	Pfizer
18804369	30	Small, non-peptide C5a receptor antagonists: part 2.	Pfizer
18595693	48	Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.	Johnson & Johnson Pharmaceutical Research and Development
16876401	48	Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity.	Jerini
10354404	60	Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a.	University of Queensland
9719594	13	Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.	University of Queensland
7658455	43	Decapeptide agonists of human C5a: the relationship between conformation and neutrophil response.	University of Nebraska Medical Center
28977749	75	Chemical Approaches to Modulating Complement-Mediated Diseases.	The University of Queensland
2066977	8	Identification and synthesis of a receptor binding site of human anaphylatoxin C5a.	Abbott Laboratories
1732557	20	Improvements in the minimum binding sequence of C5a: examination of His-67.	Abbott Laboratories
1732540	10	Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.	Abbott Laboratories
23009604	17	Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors.	Yanbian University College of Pharmacy